kent and east sussex weald hospital limited
kent and east sussex weald hospital limited Company Information
Company Number
06401000
Next Accounts
Sep 2025
Industry
Other business support service activities n.e.c.
Hospital activities
Shareholders
kent & east sussex weald hospital holdings ltd
Group Structure
View All
Contact
Registered Address
1 park row, leeds, LS1 5AB
Website
http://laing.comkent and east sussex weald hospital limited Estimated Valuation
Pomanda estimates the enterprise value of KENT AND EAST SUSSEX WEALD HOSPITAL LIMITED at £10.2m based on a Turnover of £13.1m and 0.78x industry multiple (adjusted for size and gross margin).
kent and east sussex weald hospital limited Estimated Valuation
Pomanda estimates the enterprise value of KENT AND EAST SUSSEX WEALD HOSPITAL LIMITED at £25.7m based on an EBITDA of £4.5m and a 5.65x industry multiple (adjusted for size and gross margin).
kent and east sussex weald hospital limited Estimated Valuation
Pomanda estimates the enterprise value of KENT AND EAST SUSSEX WEALD HOSPITAL LIMITED at £0 based on Net Assets of £-25m and 2.53x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Kent And East Sussex Weald Hospital Limited Overview
Kent And East Sussex Weald Hospital Limited is a live company located in leeds, LS1 5AB with a Companies House number of 06401000. It operates in the hospital activities sector, SIC Code 86101. Founded in October 2007, it's largest shareholder is kent & east sussex weald hospital holdings ltd with a 100% stake. Kent And East Sussex Weald Hospital Limited is a established, mid sized company, Pomanda has estimated its turnover at £13.1m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Kent And East Sussex Weald Hospital Limited Health Check
Pomanda's financial health check has awarded Kent And East Sussex Weald Hospital Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 2 areas for improvement. Company Health Check FAQs
6 Strong
2 Regular
2 Weak
Size
annual sales of £13.1m, make it larger than the average company (£4.4m)
£13.1m - Kent And East Sussex Weald Hospital Limited
£4.4m - Industry AVG
Growth
3 year (CAGR) sales growth of 25%, show it is growing at a faster rate (7.5%)
25% - Kent And East Sussex Weald Hospital Limited
7.5% - Industry AVG
Production
with a gross margin of 43.5%, this company has a comparable cost of product (37.1%)
43.5% - Kent And East Sussex Weald Hospital Limited
37.1% - Industry AVG
Profitability
an operating margin of 34.8% make it more profitable than the average company (8.7%)
34.8% - Kent And East Sussex Weald Hospital Limited
8.7% - Industry AVG
Employees
with 122 employees, this is above the industry average (37)
- Kent And East Sussex Weald Hospital Limited
37 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Kent And East Sussex Weald Hospital Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £107.1k, this is equally as efficient (£124.8k)
- Kent And East Sussex Weald Hospital Limited
£124.8k - Industry AVG
Debtor Days
it gets paid by customers after 100 days, this is later than average (34 days)
100 days - Kent And East Sussex Weald Hospital Limited
34 days - Industry AVG
Creditor Days
its suppliers are paid after 46 days, this is slower than average (31 days)
46 days - Kent And East Sussex Weald Hospital Limited
31 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Kent And East Sussex Weald Hospital Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 55 weeks, this is more cash available to meet short term requirements (26 weeks)
55 weeks - Kent And East Sussex Weald Hospital Limited
26 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 108.8%, this is a higher level of debt than the average (55.9%)
108.8% - Kent And East Sussex Weald Hospital Limited
55.9% - Industry AVG
KENT AND EAST SUSSEX WEALD HOSPITAL LIMITED financials
Kent And East Sussex Weald Hospital Limited's latest turnover from December 2023 is £13.1 million and the company has net assets of -£25 million. According to their latest financial statements, we estimate that Kent And East Sussex Weald Hospital Limited has 122 employees and maintains cash reserves of £11 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 13,065,000 | 8,892,000 | 7,260,000 | 6,752,000 | 5,214,000 | 6,970,000 | 7,101,000 | 6,912,000 | 6,290,000 | 6,179,000 | 5,779,000 | 21,423,000 | 155,382,000 | 113,014,000 | 0 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 7,378,000 | 5,685,000 | 5,054,000 | 4,528,000 | 3,707,000 | 4,712,000 | 4,171,000 | 4,086,000 | 3,624,000 | 3,367,000 | 3,361,000 | 17,068,000 | 151,154,000 | 112,761,000 | 0 |
| Gross Profit | 5,687,000 | 3,207,000 | 2,206,000 | 2,224,000 | 1,507,000 | 2,258,000 | 2,930,000 | 2,826,000 | 2,666,000 | 2,812,000 | 2,418,000 | 4,355,000 | 4,228,000 | 253,000 | 0 |
| Admin Expenses | 1,141,000 | 1,023,000 | 766,000 | 965,000 | 809,000 | 1,066,000 | 939,000 | 1,063,000 | 945,000 | 1,026,000 | 925,000 | 1,106,000 | 1,070,000 | 59,000 | 0 |
| Operating Profit | 4,546,000 | 2,184,000 | 1,440,000 | 1,259,000 | 698,000 | 1,192,000 | 1,991,000 | 1,763,000 | 1,721,000 | 1,786,000 | 1,493,000 | 3,249,000 | 3,158,000 | 194,000 | 0 |
| Interest Payable | 16,968,000 | 16,983,000 | 17,164,000 | 17,763,000 | 17,553,000 | 17,401,000 | 17,240,000 | 17,372,000 | 17,170,000 | 17,189,000 | 17,327,000 | 16,728,000 | 12,070,000 | 467,000 | 7,111,000 |
| Interest Receivable | 16,267,000 | 17,256,000 | 17,751,000 | 17,621,000 | 17,708,000 | 17,657,000 | 16,783,000 | 16,826,000 | 16,852,000 | 16,868,000 | 16,881,000 | 15,163,000 | 11,223,000 | 530,000 | 3,000 |
| Pre-Tax Profit | 3,845,000 | 2,457,000 | 2,027,000 | 1,117,000 | 853,000 | 1,448,000 | 1,534,000 | 1,217,000 | 1,403,000 | 1,465,000 | 1,047,000 | 1,684,000 | 2,311,000 | 257,000 | 0 |
| Tax | -904,000 | -467,000 | -381,000 | -210,000 | -169,000 | -268,000 | -295,000 | -243,000 | -284,000 | -316,000 | -243,000 | -413,000 | -612,000 | -72,000 | 0 |
| Profit After Tax | 2,941,000 | 1,990,000 | 1,646,000 | 907,000 | 684,000 | 1,180,000 | 1,239,000 | 974,000 | 1,119,000 | 1,149,000 | 804,000 | 1,271,000 | 1,699,000 | 185,000 | 0 |
| Dividends Paid | 1,995,000 | 1,331,000 | 3,329,000 | 0 | 0 | 1,473,000 | 844,000 | 2,924,000 | 765,000 | 0 | 1,500,000 | 0 | 0 | 0 | 0 |
| Retained Profit | 946,000 | 659,000 | -1,683,000 | 907,000 | 684,000 | -293,000 | 395,000 | -1,950,000 | 354,000 | 1,149,000 | -696,000 | 1,271,000 | 1,699,000 | 185,000 | 0 |
| Employee Costs | 0 | 0 | 0 | 0 | 0 | 54,000,000 | 25,000,000 | 25,000,000 | 25,000,000 | ||||||
| Number Of Employees | 6 | 6 | 6 | ||||||||||||
| EBITDA* | 4,546,000 | 2,184,000 | 1,440,000 | 1,259,000 | 698,000 | 1,192,000 | 1,991,000 | 1,763,000 | 1,721,000 | 1,786,000 | 1,493,000 | 3,249,000 | 3,158,000 | 194,000 | 0 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 267,096,000 | 268,174,000 | 301,176,000 | 338,468,000 | 323,907,000 | 316,275,000 | 320,019,000 | 318,392,000 | 324,634,000 | 301,692,000 | 279,837,000 | 279,561,000 | 260,854,000 | 112,344,000 | 0 |
| Total Fixed Assets | 267,096,000 | 268,174,000 | 301,176,000 | 338,468,000 | 323,907,000 | 316,275,000 | 320,019,000 | 318,392,000 | 324,634,000 | 301,692,000 | 279,837,000 | 279,561,000 | 260,854,000 | 112,344,000 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 2,848,000 | 2,270,000 | 0 | 0 | 0 | 0 | 7,314,000 | 127,647,000 | 163,893,000 |
| Trade Debtors | 3,607,000 | 3,003,000 | 2,677,000 | 2,702,000 | 2,611,000 | 4,274,000 | 2,443,000 | 2,325,000 | 2,422,000 | 2,297,000 | 2,239,000 | 2,125,000 | 2,045,000 | 1,707,000 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 3,633,000 | 3,922,000 | 3,104,000 | 2,353,000 | 2,947,000 | 250,000 | 2,306,000 | 1,631,000 | 1,352,000 | 797,000 | 161,000 | 69,000 | 3,550,000 | 2,918,000 | 1,429,000 |
| Cash | 10,990,000 | 11,066,000 | 9,710,000 | 12,017,000 | 12,312,000 | 7,282,000 | 4,493,000 | 4,653,000 | 8,888,000 | 8,366,000 | 8,198,000 | 10,194,000 | 4,010,000 | 958,000 | 1,118,000 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25,817,000 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 18,230,000 | 17,991,000 | 15,491,000 | 17,072,000 | 17,870,000 | 11,806,000 | 12,090,000 | 10,879,000 | 12,662,000 | 37,277,000 | 10,598,000 | 12,388,000 | 16,919,000 | 133,230,000 | 166,440,000 |
| total assets | 285,326,000 | 286,165,000 | 316,667,000 | 355,540,000 | 341,777,000 | 328,081,000 | 332,109,000 | 329,271,000 | 337,296,000 | 338,969,000 | 290,435,000 | 291,949,000 | 277,773,000 | 245,574,000 | 166,440,000 |
| Bank overdraft | 0 | 0 | 2,944,000 | 2,277,000 | 250,438,000 | 1,802,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 3,896,000 | 3,604,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 937,000 | 794,000 | 624,000 | 899,000 | 534,000 | 486,000 | 423,000 | 364,000 | 573,000 | 401,000 | 407,000 | 308,000 | 582,000 | 5,888,000 | 290,000 |
| Group/Directors Accounts | 862,000 | 862,000 | 862,000 | 1,892,000 | 4,503,000 | 862,000 | 862,000 | 862,000 | 862,000 | 809,000 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 4,943,000 | 4,427,000 | 4,050,000 | 4,032,000 | 5,189,000 | 4,712,000 | 713,000 | 20,816,000 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 4,678,000 | 4,665,000 | 4,575,000 | 4,468,000 | 4,530,000 | 4,815,000 | 3,026,000 | 2,623,000 | 2,025,000 | 3,416,000 | 3,269,000 | 3,819,000 | 1,452,000 | 562,000 | 5,793,000 |
| total current liabilities | 10,373,000 | 9,925,000 | 9,005,000 | 9,536,000 | 260,005,000 | 7,965,000 | 9,254,000 | 8,276,000 | 7,510,000 | 8,658,000 | 8,865,000 | 8,839,000 | 2,747,000 | 27,266,000 | 6,083,000 |
| loans | 299,606,000 | 296,823,000 | 382,403,000 | 423,894,000 | 156,422,000 | 396,180,000 | 277,309,000 | 278,758,000 | 279,661,000 | 278,597,000 | 279,110,000 | 279,954,000 | 273,141,000 | 218,122,000 | 160,356,000 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 768,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 341,000 | 348,000 | 156,000 | 163,000 | 178,000 | 181,000 | 129,894,000 | 136,478,000 | 105,288,000 | 111,440,000 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5,163,000 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 299,947,000 | 297,171,000 | 382,559,000 | 424,057,000 | 156,600,000 | 397,129,000 | 407,203,000 | 415,236,000 | 384,949,000 | 395,200,000 | 279,110,000 | 279,954,000 | 273,141,000 | 218,122,000 | 160,356,000 |
| total liabilities | 310,320,000 | 307,096,000 | 391,564,000 | 433,593,000 | 416,605,000 | 405,094,000 | 416,457,000 | 423,512,000 | 392,459,000 | 403,858,000 | 287,975,000 | 288,793,000 | 275,888,000 | 245,388,000 | 166,439,000 |
| net assets | -24,994,000 | -20,931,000 | -74,897,000 | -78,053,000 | -74,828,000 | -77,013,000 | -84,348,000 | -94,241,000 | -55,163,000 | -64,889,000 | 2,460,000 | 3,156,000 | 1,885,000 | 186,000 | 1,000 |
| total shareholders funds | -24,994,000 | -20,931,000 | -74,897,000 | -78,053,000 | -74,828,000 | -77,013,000 | -84,348,000 | -94,241,000 | -55,163,000 | -64,889,000 | 2,460,000 | 3,156,000 | 1,885,000 | 186,000 | 1,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 4,546,000 | 2,184,000 | 1,440,000 | 1,259,000 | 698,000 | 1,192,000 | 1,991,000 | 1,763,000 | 1,721,000 | 1,786,000 | 1,493,000 | 3,249,000 | 3,158,000 | 194,000 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | -904,000 | -467,000 | -381,000 | -210,000 | -169,000 | -268,000 | -295,000 | -243,000 | -284,000 | -316,000 | -243,000 | -413,000 | -612,000 | -72,000 | 0 |
| Stock | 0 | 0 | 0 | 0 | 0 | -2,848,000 | 578,000 | 2,270,000 | 0 | 0 | 0 | -7,314,000 | -120,333,000 | -36,246,000 | 163,893,000 |
| Debtors | -763,000 | -31,858,000 | -36,566,000 | 14,058,000 | 8,666,000 | -3,969,000 | 2,420,000 | -6,060,000 | 23,622,000 | 22,549,000 | 482,000 | 15,306,000 | 149,480,000 | 115,540,000 | 1,429,000 |
| Creditors | 143,000 | 170,000 | -275,000 | 365,000 | 48,000 | 63,000 | 59,000 | -209,000 | 172,000 | -6,000 | 99,000 | -274,000 | -5,306,000 | 5,598,000 | 290,000 |
| Accruals and Deferred Income | 13,000 | 90,000 | 107,000 | -62,000 | -1,053,000 | 2,557,000 | 403,000 | 598,000 | -1,391,000 | 147,000 | -550,000 | 2,367,000 | 890,000 | -5,231,000 | 5,793,000 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5,163,000 | 5,163,000 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 4,561,000 | 33,835,000 | 37,457,000 | -12,706,000 | -9,142,000 | 10,361,000 | -840,000 | 5,699,000 | -28,567,000 | -15,775,000 | 317,000 | -3,063,000 | -31,017,000 | -78,805,000 | -159,239,000 |
| Investing Activities | |||||||||||||||
| capital expenditure | 0 | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | 0 | ||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 292,000 | 3,604,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | -1,030,000 | -2,611,000 | 3,641,000 | 0 | 0 | 0 | 53,000 | 809,000 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | -4,943,000 | 516,000 | 377,000 | 18,000 | -1,157,000 | 477,000 | 3,999,000 | -20,103,000 | 20,816,000 | 0 |
| Long term loans | 2,783,000 | -85,580,000 | -41,491,000 | 267,472,000 | -239,758,000 | 118,871,000 | -1,449,000 | -903,000 | 1,064,000 | -513,000 | -844,000 | 6,813,000 | 55,019,000 | 57,766,000 | 160,356,000 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | -7,000 | 192,000 | -7,000 | -15,000 | -3,000 | -129,713,000 | -6,584,000 | 31,190,000 | -6,152,000 | 111,440,000 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | -701,000 | 273,000 | 587,000 | -142,000 | 155,000 | 256,000 | -457,000 | -546,000 | -318,000 | -321,000 | -446,000 | -1,565,000 | -847,000 | 63,000 | -7,108,000 |
| cash flow from financing | -2,642,000 | -28,204,000 | -37,102,000 | 260,572,000 | -234,464,000 | -7,901,000 | 1,524,000 | -7,010,000 | 4,037,000 | 41,760,000 | -813,000 | 9,247,000 | 34,069,000 | 78,645,000 | 153,249,000 |
| cash and cash equivalents | |||||||||||||||
| cash | -76,000 | 1,356,000 | -2,307,000 | -295,000 | 5,030,000 | 2,789,000 | -160,000 | -4,235,000 | 522,000 | 168,000 | -1,996,000 | 6,184,000 | 3,052,000 | -160,000 | 1,118,000 |
| overdraft | 0 | -2,944,000 | 667,000 | -248,161,000 | 248,636,000 | 1,802,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -76,000 | 4,300,000 | -2,974,000 | 247,866,000 | -243,606,000 | 987,000 | -160,000 | -4,235,000 | 522,000 | 168,000 | -1,996,000 | 6,184,000 | 3,052,000 | -160,000 | 1,118,000 |
kent and east sussex weald hospital limited Credit Report and Business Information
Kent And East Sussex Weald Hospital Limited Competitor Analysis
Perform a competitor analysis for kent and east sussex weald hospital limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in LS1 area or any other competitors across 12 key performance metrics.
kent and east sussex weald hospital limited Ownership
KENT AND EAST SUSSEX WEALD HOSPITAL LIMITED group structure
Kent And East Sussex Weald Hospital Limited has no subsidiary companies.
Ultimate parent company
2 parents
KENT AND EAST SUSSEX WEALD HOSPITAL LIMITED
06401000
kent and east sussex weald hospital limited directors
Kent And East Sussex Weald Hospital Limited currently has 4 directors. The longest serving directors include Mr Graham Beazley-Long (Jun 2011) and Mr Christopher James (Oct 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Graham Beazley-Long | England | 64 years | Jun 2011 | - | Director |
| Mr Christopher James | 57 years | Oct 2018 | - | Director | |
| Mr John Gordon | United Kingdom | 62 years | Dec 2018 | - | Director |
| Mr Matthew Templeton | England | 51 years | Feb 2019 | - | Director |
P&L
December 2023turnover
13.1m
+47%
operating profit
4.5m
+108%
gross margin
43.6%
+20.69%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-25m
+0.19%
total assets
285.3m
0%
cash
11m
-0.01%
net assets
Total assets minus all liabilities
kent and east sussex weald hospital limited company details
company number
06401000
Type
Private limited with Share Capital
industry
82990 - Other business support service activities n.e.c.
86101 - Hospital activities
incorporation date
October 2007
age
18
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
PRICEWATERHOUSECOOPERS LLP
address
1 park row, leeds, LS1 5AB
Bank
HALIFAX BANK OF SCOTLAND
Legal Advisor
-
kent and east sussex weald hospital limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to kent and east sussex weald hospital limited. Currently there are 1 open charges and 0 have been satisfied in the past.
kent and east sussex weald hospital limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for KENT AND EAST SUSSEX WEALD HOSPITAL LIMITED. This can take several minutes, an email will notify you when this has completed.
kent and east sussex weald hospital limited Companies House Filings - See Documents
| date | description | view/download |
|---|
